MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
MediGene SG&A Expense (TTM)
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.795M |
| December 31, 2023 | 10.09M |
| June 30, 2023 | 8.437M |
| December 31, 2022 | 10.50M |
| June 30, 2022 | 11.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.047M |
| June 30, 2021 | 8.334M |
| December 31, 2020 | 9.706M |
| June 30, 2020 | 5.028M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| InflaRx NV | 16.14M |
| BioNTech SE | 833.57M |
| Immatics NV | 63.90M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |